T he antibiotic vancomycin, recommended as first-line treatment for infection caused by the deadly superbug C. difficile (C.

Antibiotics can disrupt gut microbiota, leading to potential recurrences of Clostridioides difficile infections (CDI). New therapies like fecal microbiota transplantation (FMT) and monoclonal ...

Clostridioides difficile is a type of bacteria that often affects people who have been taking antibiotics, GST Micro LLC ...

December 10th 2024EP. 5: Key Data Supporting the Use of Rebyota in Patients With Recurrent C Difficile Infections The panelist discusses Rebyota, a treatment approved by the FDA for preventing ...

Patients suffering from a recurrent infection with the C difficile bacteria have benefited from a microbiome treatment from Rebiotix. The results from the open label phase 2 trial confirm that ...

The following is a summary of “Oral Capsule FMT Combined With Bezlotoxumab Is a Successful Rescue Protocol Following Failure ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Diagnosis and treatment of CDI represents a challenge to the clinician. As recommended by several guidelines, a key measure for treating CDI ideally includes the discontinuation of concurrent ...

The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...

There are currently no C. difficile vaccines available, and the main treatment for the infection is a lengthy course of ...

Pharmaceuticals announced updates on Phase 3 Readiness for Ibezapolstat in C. difficile Infection based on recent FDA and EMA ...

Once C-diff is in the ascendancy it can be very hard to shift – the traditional treatment is antibiotics but a significant number of patients do not respond and are left with relentless and ...